skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Experience with and potential of Cf-252 therapy for other tumors: Lexington clinical trials

Journal Article · · Nucl. Sci. Appl.; (United States)
OSTI ID:6708381

Clinical observations of tumor response in a variety of sites to Cf-252 (Cf) neutron brachytherapy (NT) are described. Many tumors which are accessible and easily implanted are suitable for Cf-NT, but in advanced stages, must be integrated into a more comprehensive program of local, regional and systemic therapy. With local tumor clearance and control, there should be treatment for regional disease using conventional photon radiotherapy; adjuvant therapies for disseminated disease using systemic therapy is also needed. While potential for therapy exists for Cf-NT treatment of many tumors, additional clinical trials carried out in a variety of global settings are needed where different tumors are common and are available for studies. Tumors suitable for study include e.g. cervix, uterus, vagina, tonsil-oropharynx, anterior oral cavity, prostate, female urethra, nasopharynx, anus and rectum, malignant glioma, parotid, perhaps esophagus, bladder, non-oat cell lung, localized sarcoma and melanoma, etc.

Research Organization:
Radiation Therapy Oncology Center, Univ. of Kentucky Medical Center, Lexington, KY
OSTI ID:
6708381
Journal Information:
Nucl. Sci. Appl.; (United States), Vol. 2:3
Country of Publication:
United States
Language:
English